You are here:Home-SARS-CoV-2 Related-SARS-CoV-2 Inhibitors-NSC 621601
NSC 621601

Chemical Structure : NSC 621601

CAS No.: 102036-11-3

NSC 621601 (Compound Q34)

Catalog No.: PC-72328Not For Human Use, Lab Use Only.

NSC 621601 (Compound Q34) is a potent, specific inhibitor of SARS-CoV-2 cellular entry with IC50 of 15 uM.

Packing Price Stock Quantity
25 mg Get quote
100 mg Get quote
250 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

NSC 621601 (Compound Q34) is a potent, specific inhibitor of SARS-CoV-2 cellular entry with IC50 of 15 uM.
Compound Q34 inhibits cellular entry of virus mediated by the SARS-CoV-2 spike protein specifically, but not by the VSV-G glycoprotein.
Compound Q34 inhibits SARS-CoV-2 cellular entry with a broad safety dose range.
Compound Q34 inhibits infection of SARS-CoV-2 pseudovirus in a dose-dependent manner and exhibits no cytotoxicity in a broad dose range.
Compound Q34 inhibits authentic SARS-CoV-2 infection of hACE2-HEK cells.
Compound Q34 inhibits authentic SAR-CoV-2 infection of human iPSC-derived neurons and astrocytes, and human lung cells.

Physicochemical Properties

M.Wt 354.454
Formula C20H26N4O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Month
Shipping
Solubility

Chemical Name/SMILES

References

1. Qi Cui, et al. iScience. 2022 Jan 21;25(1):103684.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: